http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180049535-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c650bc189c0fd43656877b5aada02fea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7014 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394fb34377a72acdf9196c5942ace824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_506bcee506a6ca44f413bbdebbfa5439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe75da803db084d5cf452cd4c57df1a |
| publicationDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180049535-A |
| titleOfInvention | Composition for diagnosing inflammatory reaction-mediated angiogenesis disease |
| abstract | The present invention relates to a composition for diagnosing neovascularization diseases; A kit comprising the same; A pharmaceutical composition for preventing or treating a neovascularization disease; And a method for measuring the occurrence of a neovascularization disease. A composition for diagnosing a neovascularization disease according to the present invention; A kit comprising the same; A pharmaceutical composition for preventing or treating a neovascularization disease; And a method for measuring the incidence of a neovascularization disease, it is possible to more clearly diagnose a neovascularization disease and be useful for the prevention or treatment of the neovascularization diseases. Further, the composition for diagnosing a neovascularization disease according to the present invention; A kit comprising the same; A pharmaceutical composition for preventing or treating a neovascularization disease; And a method for measuring the occurrence of a neovascularization disease are the molecular mechanisms for the neovascularization disease mediated by the inflammatory reaction and can be usefully utilized in the field. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-200489690-Y1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102091803-B1 |
| priorityDate | 2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.